ATE242242T1 - Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten - Google Patents

Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten

Info

Publication number
ATE242242T1
ATE242242T1 AT99944965T AT99944965T ATE242242T1 AT E242242 T1 ATE242242 T1 AT E242242T1 AT 99944965 T AT99944965 T AT 99944965T AT 99944965 T AT99944965 T AT 99944965T AT E242242 T1 ATE242242 T1 AT E242242T1
Authority
AT
Austria
Prior art keywords
imidazo
pyridine
derivatives
treatment
gastrointestinal diseases
Prior art date
Application number
AT99944965T
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE242242T1 publication Critical patent/ATE242242T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99944965T 1998-08-21 1999-08-18 Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten ATE242242T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9802793A SE9802793D0 (sv) 1998-08-21 1998-08-21 New compounds
PCT/SE1999/001401 WO2000010999A2 (en) 1998-08-21 1999-08-18 New compounds

Publications (1)

Publication Number Publication Date
ATE242242T1 true ATE242242T1 (de) 2003-06-15

Family

ID=20412306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944965T ATE242242T1 (de) 1998-08-21 1999-08-18 Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten

Country Status (21)

Country Link
US (1) US6613775B1 (de)
EP (1) EP1105390B1 (de)
JP (1) JP2002523414A (de)
KR (1) KR20010072797A (de)
CN (1) CN1161355C (de)
AR (1) AR020225A1 (de)
AT (1) ATE242242T1 (de)
AU (1) AU770511B2 (de)
BR (1) BR9913102A (de)
CA (1) CA2339372A1 (de)
DE (1) DE69908608T2 (de)
DK (1) DK1105390T3 (de)
ES (1) ES2201769T3 (de)
IL (1) IL141165A0 (de)
MY (1) MY121387A (de)
NO (1) NO20010861L (de)
NZ (1) NZ509744A (de)
PT (1) PT1105390E (de)
SE (1) SE9802793D0 (de)
WO (1) WO2000010999A2 (de)
ZA (1) ZA200100911B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SI1606261T1 (sl) 2003-03-10 2010-03-31 Nycomed Gmbh Novi postopek za pripravo roflumilasta
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
EP1974730A1 (de) 2003-11-03 2008-10-01 AstraZeneca AB Imidazo[1,2-a]pyridin-Derivate zur Behandlung von Schlafstörungen durch stummen gastroösophagealen Reflux
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006013195A1 (en) * 2004-08-02 2006-02-09 Altana Pharma Ag 5-substituted 1h-pyrrolo[3,2-b]pyridines
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
US8663694B2 (en) 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
EP1861095A1 (de) * 2005-03-24 2007-12-05 Glaxo Group Limited Derivate von imidazo(1,2-a)pyridin als nützliche medikamente zur behandlung von magen-darm-erkrankungen
ES2540232T3 (es) 2009-07-08 2015-07-09 Dermira (Canada), Inc. Análogos de TOFA útiles en el tratamiento de trastornos o afecciones dermatológicas
MX2012000275A (es) 2009-07-09 2012-02-08 Raqualia Pharma Inc Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (de) 1981-06-26 1986-03-05 Schering Corporation Imidazo(1,2-a)pyridine und -pyrazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers

Also Published As

Publication number Publication date
WO2000010999A2 (en) 2000-03-02
CN1161355C (zh) 2004-08-11
ES2201769T3 (es) 2004-03-16
DE69908608D1 (de) 2003-07-10
NZ509744A (en) 2003-05-30
EP1105390A2 (de) 2001-06-13
JP2002523414A (ja) 2002-07-30
NO20010861L (no) 2001-04-10
IL141165A0 (en) 2002-11-10
BR9913102A (pt) 2001-05-08
MY121387A (en) 2006-01-28
CA2339372A1 (en) 2000-03-02
AU5767899A (en) 2000-03-14
EP1105390B1 (de) 2003-06-04
SE9802793D0 (sv) 1998-08-21
AU770511B2 (en) 2004-02-26
KR20010072797A (ko) 2001-07-31
WO2000010999A3 (en) 2000-06-02
DK1105390T3 (da) 2003-09-22
ZA200100911B (en) 2002-05-02
HK1036274A1 (en) 2001-12-28
CN1323308A (zh) 2001-11-21
PT1105390E (pt) 2003-10-31
AR020225A1 (es) 2002-05-02
US6613775B1 (en) 2003-09-02
NO20010861D0 (no) 2001-02-20
DE69908608T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE308527T1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
ATE242242T1 (de) Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten
DE69730156D1 (de) 5-Pyrimidinyl-4-yl-imidazole derivatives useful for the treatment of CSBP/RK/p38 mediated diseases
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO990722D0 (no) FremgangsmÕte for behandling av hjertesvikt
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
ATE386742T1 (de) Imidazonaphthyridine
IL113263A0 (en) Imidazo pyridine compounds and pharmaceutical compositions for the treatment of gastrointestinal diseases
ID29790A (id) PENGGUNAAN IMIDAZO(1,5-a)-PIRIDO(3,2-e)-PIRAZINON SEBAGAI OBAT
PT971922E (pt) Compostos de tetra-hidropirido
ATE261434T1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
ATE381568T1 (de) Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen
ATE256126T1 (de) 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
DE69902071D1 (de) Verfahren zur Herstellung von 2-substituierten Pyridinen
ATE261965T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
SI1105390T1 (en) Imidazo(1,2-a)pyridine derivatives for the treatment of gastrointestinal diseases
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
IS2153B (is) S-nítrósóþíól til meðferðar við blóðrásartruflunum
ATE298239T1 (de) Immunomodulierende zusammensetzungen enthaltend harnstoff derivate zur behandlung von entzündungskrankheiten
DE60008377D1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
ATE321044T1 (de) C-6 ringsubstituierte pyrido(1,2- a)benzimidazolderivate zur behandlung von störungen des zentralen nervensystems

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1105390

Country of ref document: EP

REN Ceased due to non-payment of the annual fee